1056 related articles for article (PubMed ID: 27732805)
1. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
Welch HG; Prorok PC; O'Malley AJ; Kramer BS
N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. Effect of three decades of screening mammography on breast-cancer incidence.
Bleyer A; Welch HG
N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
[TBL] [Abstract][Full Text] [Related]
4. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
7. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
9. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
[TBL] [Abstract][Full Text] [Related]
11. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
12. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
[TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
14. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
16. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
17. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
18. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
[TBL] [Abstract][Full Text] [Related]
19. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
20. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.
Helvie MA; Chang JT; Hendrick RE; Banerjee M
Cancer; 2014 Sep; 120(17):2649-56. PubMed ID: 24840597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
